Qian Zhang | Nano-Biomedical Engineering | Best Researcher Award

Assoc. Prof. Dr. Qian Zhang | Nano-Biomedical Engineering | Best Researcher Award

Shanghai Jiao Tong University | China

Assoc. Prof. Dr. Qian Zhang is an accomplished nanomedicine researcher based at Shanghai Jiao Tong University, specializing in the synthesis, surface modification, and biomedical applications of colloidal and magnetic nanomaterials. She earned her Doctor of Science from Philipps-Universität Marburg under Prof. Wolfgang Parak and holds Master’s and Bachelor’s degrees from Sichuan Agriculture University and Qingdao Agriculture University, respectively. Assoc. Prof. Dr. Qian Zhang’s career trajectory includes postdoctoral research, assistant and associate researcher roles at SJTU, and a visiting scientist position at the Weizmann Institute of Science in Israel. Her research focuses on the design of drug delivery systems integrating diagnosis and treatment, interaction of nanomaterials with cancer cells, and physico-chemical characterization of metal-doped magnetic nanomaterials for MRI applications. She has successfully led multiple national and Shanghai-based research projects, including studies on ferromanganese-based nanocarriers for ferroptosis induction and immunotherapy, heat-induced hybrid iron oxide nanocarriers combined with siRNA for early cancer diagnosis, and urine exosomal drug delivery systems for prostate cancer treatment. Assoc. Prof. Dr. Qian Zhang has authored two influential books and 68 publications in high-impact journals, accruing 4,842 citations with an h-index of 29, reflecting her strong scientific influence. Her work demonstrates remarkable innovation, translational relevance, and international collaboration, establishing her as a leading figure in nanomedicine and targeted cancer therapy.

Profile: Scopus

Featured Publications

Zhang, Q. (2026). Element-doped ferrite nanoparticles: From magnetic property tuning to biomedical applications. Coordination Chemistry Reviews, 548, 217151.

Zhao, Y., Zhang, Q., Zhang, A., Pan, S., Cheng, J., Ning, J., … Wang, C. (2025). A novel near-infrared AP-M@AntiACLY detection probe based on SERS to trace detection of serum ACLY for early diagnosis of pediatric sepsis. Sensors and Actuators B: Chemical.

Jin, Y., Huang, J., Tang, Y., Li, Z., Zhang, A., Yang, Z., … Zhang, Q. (2024). Boosting ferroptosis by intervention of redox balance and synergetic with photothermal/photodynamic therapy for suppression of pancreatic cancer. Chemical Engineering Journal, 497.

[Author(s) not fully listed]. (2024). Flower-shaped magnetic fluorescent nanoparticles based lateral flow biosensor for highly sensitive detection of cardiac troponin I. Sensors and Actuators B: Chemical.

[Author(s) not fully listed]. (2024). An ingestible near-infrared fluorescence capsule endoscopy for specific gastrointestinal diagnoses. Biosensors and Bioelectronics.

 

Sémah Tagougui | Exercise | Best Researcher Award

Dr. Sémah Tagougui | Exercise | Best Researcher Award

Dr. Sémah Tagougui at University of Lille, France

Dr. Sémah Tagougui is a University Lecturer at the University of Lille  and an internationally recognized researcher in exercise physiology, type 1 diabetes, and metabolic health 🧠. With a Ph.D. in Life Sciences and postdoctoral training in Brussels and Montreal , he leads innovative projects on glycemic control, including AI-based tools  and insulin technologies. He has secured competitive grants , published high-impact research 📚, and regularly speaks at global conferences. Honored with the RIPEC Award for Scientific Excellence 🏅, Dr. Tagougui’s work bridges clinical science and real-world application for chronic disease management 🩺.

Publication Profile

Orcid

Scopus

Google Scholar

Academic Background

Dr. Sémah Tagougui holds a Ph.D. in Life Sciences from the University of Lille , where his research focused on muscle and cerebral oxygenation in individuals with type 1 diabetes 💉. He also earned a Master’s degree in Adapted Physical Activities and Health from the same university 🏃‍♂️🩺. He completed two prestigious postdoctoral fellowships—one in Brussels  and another at the Institute of Clinical Research in Montreal . In 2022, he received his Habilitation to Supervise Research, a mark of academic excellence 🏅. His educational path reflects a strong commitment to clinical and physiological research 📚.

Professional Experience

Dr. Sémah Tagougui is currently serving as a University Lecturer at the University of Lille , where he has been actively teaching and conducting research since 2019 📚. He previously held roles as an ATER and doctoral tutor at the same university, shaping future professionals in sports science and health 🧠. His international experience includes postdoctoral research positions in Brussels  and Montreal , focusing on diabetes, exercise physiology, and metabolic health 💉. Dr. Tagougui also plays key roles in international collaborative projects , thesis committees , and scientific advisory panels, demonstrating leadership in academic and clinical research 🔬🩺.

Awards and Honors

Dr. Sémah Tagougui has received several prestigious awards in recognition of his outstanding contributions to science and health research 💉. In 2023, he was honored with the RIPEC Award for Scientific Excellence by the French National Council of Universities 🎖️. He also secured multiple competitive grants, including the Young Francophone Researcher Grant and the FRM Research Hope Grant 📑. His invited speaker roles at renowned institutions and conferences 🌍 further highlight his influence in the field. These accolades reflect his dedication to advancing knowledge in type 1 diabetes, exercise science, and metabolic health 🔬.

Research Focus

Dr. Sémah Tagougui’s research centers on the intersection of type 1 diabetes, exercise physiology, and metabolic health 💉. His work explores how physical activity impacts glycemic control, muscle oxygenation, and cerebral function in individuals with diabetes . He is actively developing AI-powered tools for personalized blood glucose prediction  and has contributed to cutting-edge studies on insulin technologies, artificial pancreas systems, and exercise-induced glucose fluctuations 🧬. Collaborating internationally , his goal is to transform exercise from a risk factor into a therapeutic strategy for diabetes management 🌍. His research has real-world clinical impact and global relevance 🌐📚.

Publication Top Notes

Acute cocoa flavanol improves cerebral oxygenation without enhancing executive function at rest or after exercise
📅 Year: 2016 | 🔢 Cited by: 68

The benefits and limits of technological advances in glucose management around physical activity in patients with type 1 diabetes
📅 Year: 2019 | 🔢 Cited by: 62

Muscle oxygen supply impairment during exercise in poorly controlled type 1 diabetes
📅 Year: 2015 | 🔢 Cited by: 62

Artificial pancreas systems and physical activity in patients with type 1 diabetes: challenges, adopted approaches, and future perspectives
📅 Year: 2019 | 🔢 Cited by: 52

Aerobic fitness influences cerebral oxygenation response to maximal exercise in healthy subjects
📅 Year: 2015 | 🔢 Cited by: 38

A single-blind, randomised, crossover study to reduce hypoglycaemia risk during postprandial exercise with closed-loop insulin delivery in adults with type 1 diabetes
📅 Year: 2020 | 🔢 Cited by: 35

Muscle oxygen supply and use in type 1 diabetes: is there a limiting step?
📅 Year: 2020 | 🔢 Cited by: 33

Barriers to physical activity in children and adults living with type 1 diabetes: a complex link with real-life glycemic excursions
📅 Year: 2023 | 🔢 Cited by: 31

Changes in accuracy of continuous glucose monitoring using Dexcom G4 Platinum during moderate intensity exercise in type 1 diabetes
📅 Year: 2019 | 🔢 Cited by: 27

Regional cerebral hemodynamic response to incremental exercise is blunted in poorly controlled patients with uncomplicated type 1 diabetes
📅 Year: 2015 | 🔢 Cited by: 22

Minimizing risk of exercise-induced glucose fluctuations in type 1 diabetes using insulin infusion: overview of strategies
📅 Year: 2021 | 🔢 Cited by: 19

Effectiveness of Ramadan fasting and concurrent training in obesity management: is the combination worth the weight?
📅 Year: 2023 | 🔢 Cited by: 18

Conclusion

Dr. Sémah Tagougui is an outstanding candidate for the Best Researcher Award due to his exemplary academic background, including a distinguished Ph.D. and postdoctoral fellowships, along with his habilitation to supervise research, demonstrating senior scientific leadership. As a University Lecturer at the University of Lille, he has led numerous competitive international grants and acted as Principal Investigator on innovative projects bridging exercise physiology and diabetes management. His high-impact publications in top journals and extensive citations reflect significant contributions to the field. Dr. Tagougui’s strong international collaborations, invited speaker roles, and translational focus on improving clinical outcomes highlight his sustained excellence, making him highly deserving of this honor.